Amifostine (Ethyol®) : Dosing, administration and patient management guidelinesBUKOWSKI, R. M.European journal of cancer (1990). 1996, Vol 32, pp S46-S49, issn 0959-8049, SUP4Article

The need for cytoprotectionBUKOWSKI, R. M.European journal of cancer (1990). 1996, Vol 32, pp S2-S4, issn 0959-8049, SUP4Article

Natural history and therapy of metastatic renal cell carcinoma : The role of interleukin-2BUKOWSKI, R. M.Cancer. 1997, Vol 80, Num 7, pp 1198-1220, issn 0008-543XConference Paper

Amifostine (ETHYOL®): current and future applications in cytoprotectionBUKOWSKI, R. M.European journal of cancer (1990). 1996, Vol 32, pp S1-S49, issn 0959-8049, 51 p., SUP4Serial Issue

Exploration of platinum-based dose-intensive chemotherapy strategies with amifostine (Ethyol®)SCHUCHTER, L. M.European journal of cancer (1990). 1996, Vol 32, pp S40-S42, issn 0959-8049, SUP4Article

Cytokine combinations : Therapeutic use in patients with advanced renal cell carcinomaBUKOWSKI, R. M.Seminars in oncology. 2000, Vol 27, Num 2, pp 204-212, issn 0093-7754Article

The potential role of Amifostine (Ethyol®) in haematological malignanciesGORIN, N. C.European journal of cancer (1990). 1996, Vol 32, pp S31-S39, issn 0959-8049, SUP4Article

Chemotherapy trials in malignant pheochromocytoma: report of two patients and review of the literatureBUKOWSKI, R. M; VIDT, D. G.Journal of surgical oncology. 1984, Vol 27, Num 2, pp 89-92, issn 0022-4790Article

The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions, and plasma exchangeSHEPARD, K. V; BUKOWSKI, R. M.Seminars in hematology. 1987, Vol 24, Num 3, pp 178-193, issn 0037-1963Article

Combination chemotherapy for metastatic carcinoma of the ampulla of vater-report of three cases = Polychimiothérapie pour cancer métastatique de l'ampoule de Vater. Compte rendu de trois casBUKOWSKI, R. M; HERMANN, R. E; THEODORS, A et al.Journal of surgical oncology. 1984, Vol 25, Num 4, pp 284-286, issn 0022-4790Article

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinomaHUTSON, T. E; BUKOWSKI, R. M; MARTELL, B et al.British journal of cancer. 2014, Vol 110, Num 5, pp 1125-1132, issn 0007-0920, 8 p.Article

A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid TumorsRINI, Brian I; GARCIA, Jorge A; TRIOZZI, Pierre et al.Clinical cancer research (Print). 2009, Vol 15, Num 19, pp 6277-6283, issn 1078-0432, 7 p.Article

T-cell adoptive immunotherapy of metastatic renal cell carcinoma. CommentaryPLAUTZ, G. E; BUKOWSKI, R. M; JAFFEE, E. M et al.Urology (Ridgewood, NJ). 1999, Vol 54, Num 4, pp 617-624, issn 0090-4295Article

Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma : Clinical relevance and effects of cytokine therapyBUKOWSKI, R. M; RAYMAN, P; NOVICK, A et al.Clinical cancer research. 1998, Vol 4, Num 10, pp 2337-2347, issn 1078-0432Article

Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinomaKUDOH, S; REDOVAN, C; RAYMAN, P et al.Journal of immunotherapy with emphasis on tumor immunology. 1997, Vol 20, Num 6, pp 479-487, issn 1067-5582Article

Adenocarcinoma of the esophagus and gastroesophageal junction : clinical and pathologic assessment of response to induction chemotherapyADELSTEIN, D. J; RICE, T. W; BOYCE, G. A et al.American journal of clinical oncology. 1994, Vol 17, Num 1, pp 14-18, issn 0277-3732Article

Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma : clinical and biologic effectsBUKOWSKI, R. M; MURTHY, S. A; BUDD, G. T et al.Journal of immunotherapy. 1994, Vol 15, Num 4, pp 273-282, issn 1053-8550Article

Renal masses simulating primary renal cell carcinoma in patients with advanced malignanciesSAMPAIO, C. A; MCLAIN, D; KLEIN, E et al.The Journal of urology. 1994, Vol 151, Num 6, pp 1505-1508, issn 0022-5347Article

Phase I study of WR-2721 and carboplatinBUDD, G. T; GANAPATHI, R; BAUER, L et al.European journal of cancer. Part A. 1993, Vol 29, Num 8, pp 1122-1127Article

A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinomaBUKOWSKI, R. M; INOSHITA, G; YALAVARTHI, P et al.Cancer. 1992, Vol 69, Num 4, pp 889-892, issn 0008-543XArticle

Phase II study of platinum and mitoxantrone in metastatic prostate cancer : a southwest oncology group studyOSBORNE, C. K; BLUMENSTEIN, B. A; CRAWFORD, E. D et al.European journal of cancer (1990). 1992, Vol 28, Num 2-3, pp 477-478, issn 0959-8049Conference Paper

Immunologic studies of alveolar macrophages from patients with metastatic renal cell carcinomaTHOMASSEN, M. J; BARNA, B. P; WIEDEMANN, H. P et al.The American review of respiratory disease. 1990, Vol 141, Num 5, pp 1256-1258, issn 0003-0805, 3 p., . 1Article

Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy: its distinction from early gastric carcinomaPETRAS, R. E; HART, W. R; BUKOWSKI, R. M et al.Cancer. 1985, Vol 56, Num 4, pp 745-750, issn 0008-543XArticle

Phase II: evaluation of amsacrine (m-AMSA) in solid tumors, myeloma and lymphoma: a university of arizona and Southwest Oncology Group study = Essai phase II de l'amsacrine (m-AMSA) dans les tumeurs solides, les myélomes et les lymphomes: une étude de l'Université d'Arizona et du Southwest Oncology GroupAHMANN, F. R; MEYSKENS, F. L. JR; JONES, S. E et al.Cancer treatment reports. 1983, Vol 67, Num 7-8, pp 697-700, issn 0361-5960Article

Multi-sensor system based on phase detection, an LED array, and luminophore-doped xerogelsCHODAVARAPU, V. P; BUKOWSKI, R. M; KIM, S. J et al.Electronics Letters. 2005, Vol 41, Num 18, pp 1031-1033, issn 0013-5194, 3 p.Article